Manuscripts

Search by keyword, year, or author name.

Showing 1554 manuscripts.

Phase I Study of Abacavir (1592U89) Alone and in Combination With Other Antiretroviral Agents in Infants and Children with Human Immunodeficiency Virus Infection

Mark W. Kline, Suzette Blanchard, Courtney V. Fletcher, Jerry L. Shenep, Ross E. McKinney, Richard Brundage, Mary Culnane, Russell B. Van Dyke, Wayne M. Dankner, Andrea Kovacs, Jim McDowell, Seth Hetherington. Phase I Study of Abacavir (1592U89) Alone and in Combination With Other Antiretroviral Agents in Infants and Children with Human Immunodeficiency Virus Infection. Pediatrics. 1999. 103: 1-5.

Year

1999

Journal

Pediatrics

Efficacy of Zidovudine and Human Immunodeficiency Virus (HIV) Hyperimmune Immunoglobulin For Reducing Perinatal HIV Transmission from HIV-Infected Women with Advanced HIV Disease: Results of Pediatric AIDS Clinical Trials Group Protocol 185

E. Richard Stiehm, John S. Lambert, Lynne M. Mofenson, James Bethel, Jean Whitehouse, Robert Nugent, John Moye, Mary Glen Fowler, Bonnie Mathieson, Patricia Reichelderfer, Georg J. Nemo, James Korelitz, William A. Meyer, Christine V. Sapan, Eleanor Jimenez, Jorge Gandia, Gwendolyn Scott, Mary Jo O'Sullivan, Andrea Kovacs, Alice Stek, William T. Shearer, Hunter Hammill. Efficacy of Zidovudine and Human Immunodeficiency Virus (HIV) Hyperimmune Immunoglobulin For Reducing Perinatal HIV Transmission from HIV-Infected Women with Advanced HIV Disease: Results of Pediatric AIDS Clinical Trials Group Protocol 185. Journal of Infectious Diseases. 1999. 179: 567-75.

Year

1999

Journal

Journal of Infectious Diseases

Pharmacokinetics Of Dapsone Administered Daily And Weekly In Human Immunodeficiency Virus-Infected Children

Mirochnick M, Ellen Rae Cooper, McIntosh K, Xu J, Lindsey J, Jacobus D, Mofenson LM, Sullivan JL, Dankner W, Frenkel LM, Nachman S, Wara DW, Johnson D, Bonagura V, Rathore M, Coleen K. Cunningham, James McNamara. Pharmacokinetics Of Dapsone Administered Daily And Weekly In Human Immunodeficiency Virus-Infected Children. Antimicrobial Agents and Chemotherapy. 1999. 43: 2586-91.

Year

1999

Journal

Antimicrobial Agents and Chemotherapy

Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.

Cunningham B, Oleske J, Culnane M, Fowler M, Lee SS, McSherry G, Brady M, O'Donnell K, Mofenson L, Gortmaker SL, Shapiro DE, Scott G, Jimenez E, Moore EC, Diaz C, Flynn PM. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.. The Journal of the American Medical Association. 1999. 281: 151-157. PMID: 9917118

Year

1999

Journal

The Journal of the American Medical Association

Recent Developments In Pediatric HIV-1 Infection

Burns DN, Mofenson LM. Recent Developments In Pediatric HIV-1 Infection. Lancet. 1999. 354: SII1-6.

Year

1999

Journal

Lancet

Virologic and Immunologic Response To Nucleoside Reverse-Transcriptase Inhibitor therapy Among HIV-Infected Infants and Children

Palumbo P, Raskino C, Fiscus S, Pahwa S, Schutzbank T, Spector S, Baker CJ, Englund JA. Virologic and Immunologic Response To Nucleoside Reverse-Transcriptase Inhibitor therapy Among HIV-Infected Infants and Children. Journal of Infectious Diseases. 1999. 179: 576-83.

Year

1999

Journal

Journal of Infectious Diseases

Systematic Pharmacokinetics and Cellular Pharmacology Of Zidovudine In HIV-1Infected Women and Newborn Infants

John H. Rodman, Patricia M. Flynn, Brian Robbins, Eleanor Jimenez, Arlene D. Bardeguez, Jose F. Rodriguez, Suzette Blanchard, Arnold Fridland. Systematic Pharmacokinetics and Cellular Pharmacology Of Zidovudine In HIV-1Infected Women and Newborn Infants. Journal of Infectious Diseases. 1999. 180: 1844-50.

Year

1999

Journal

Journal of Infectious Diseases

HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failed

Andrew R. Zolopa, Robert Shafer, Ann Warford, Jose G. Montoya, Philip Hsu, David Katzenstein, Thomas C. Merigan, Brad Efron. HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failed. Annals of Internal Medicine. 1999. 131: 813-21.

Year

1999

Journal

Annals of Internal Medicine

The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements. The Women Infant Transmission Study Clinics. Virology Quality Assurance Program.

Donald Brambilla, Patricia S. Reichelderfer, James W. Bremer, David E. Shapiro, Ronald C. Hershow, David A. Katzenstein, Scott M. Hammer, Brooks Jackson, Ann C. Collier, Rhoda S. Sperling, Mary-Glen Fowler, Robert W. Coombs. The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements. The Women Infant Transmission Study Clinics. Virology Quality Assurance Program.. AIDS. 1999. 13: 2269-79.

Year

1999

Journal

AIDS

Toxicity and Efficacy of Daily vs. Weekly Dapsone for Prevention of Pneumocystis Carinii Pneumonia in Children with Human Immunodeficiency Virus

Kenneth McIntosh, Ellen Cooper, Jing Xu, Mark Mirochnick, Jane Lindsey, David Jacobus, Lynne Mofenson, Ram Yogev, Stephen A. Spector, John L. Sullivan, Henry Sacks, Andrea Kovacs, Sharon Nachman, John Sleasman, Vincent Bonagura, James McNamara. Toxicity and Efficacy of Daily vs. Weekly Dapsone for Prevention of Pneumocystis Carinii Pneumonia in Children with Human Immunodeficiency Virus. Pediatric Infectious Disease Journal. 1999. 18: 432-9.

Year

1999

Journal

Pediatric Infectious Disease Journal